Extragonadal germ cell tumor (EGGCT) encompasses germ cell neoplasms developing in locations outside the gonads, accounting for 2-5% of all germ cell tumors. The retroperitoneum is the most common extragonadal site, comprising approximately 60% of all retroperitoneal EGGCTs. The mediastinum is the second most common site. Histological subtypes are identical to gonadal germ cell tumors: seminoma, mature/immature teratoma, yolk sac tumor, embryonal carcinoma, choriocarcinoma, and mixed type. In the retroperitoneal/peritoneal location, it usually presents as a large mass in young males (20-35 years). Tumor markers (AFP, beta-hCG, LDH) play a critical role in diagnosis and follow-up. Treatment varies by histological subtype; seminomas are radio/chemosensitive, while non-seminomatous tumors require cisplatin-based chemotherapy + surgical resection.
Age Range
15-45
Peak Age
30
Gender
Male predominant
Prevalence
Rare
The pathogenesis of extragonadal germ cell tumors is explained by two main theories. First, the embryonic germ cell migration hypothesis: primordial germ cells may remain ectopically in midline structures (retroperitoneum, mediastinum, pineal region) during migration from the yolk sac to the gonadal ridge and undergo neoplastic transformation. Second, the reverse migration hypothesis: a primary tumor developing in the gonad undergoes spontaneous regression ('burned-out' testicular tumor) and spreads to the retroperitoneum as metastasis. On CT, it appears as a large, heterogeneous retroperitoneal mass; heterogeneity reflects necrosis, hemorrhage, cystic degeneration, and coexistence of different histological components (solid, cystic, fat, calcification). Fat and calcification in teratoma components provide diagnostic clues — fat tissue shows negative HU, calcifications high HU. Seminomas appear as more homogeneous solid masses, while non-seminomatous tumors show more heterogeneous structure. On MRI, T2 hyperintensity reflects cystic/necrotic areas, T1 hyperintensity reflects hemorrhage or mucoid content.
Coexistence of fat density (negative HU) and calcification (high HU) within a retroperitoneal mass is a highly specific finding for germ cell tumor with teratoma component. Particularly in a young male with retroperitoneal location, this finding strongly supports extragonadal germ cell tumor diagnosis and mandates testicular ultrasound for 'burned-out' tumor investigation.
On CT, a large (frequently >10 cm), heterogeneous mass located in the retroperitoneum is observed. The mass typically grows anterior or lateral to the aorta, displacing the kidneys and major vascular structures. Internal structure is markedly heterogeneous: solid enhancing areas, cystic/necrotic areas, hemorrhagic foci, and depending on subtype, may contain fat and calcification. Seminomas appear as relatively more homogeneous solid masses, while non-seminomatous tumors demonstrate marked heterogeneity. Invasion or compression of great vessels (aorta, vena cava, iliac vessels) should be evaluated.
Report Sentence
Large, heterogeneous mass in the retroperitoneum containing solid enhancing areas and cystic/necrotic components; extragonadal germ cell tumor should be considered in the differential diagnosis in a young male patient.
In EGGCT with teratoma component, fat density (-20 to -100 HU) and calcification (>100 HU) are seen together within the mass. Fat-calcification coexistence is highly specific for teratoma diagnosis. In mature teratoma, fat-fluid level and organized calcification (tooth or bone structures) may be seen within a well-defined cystic mass. In immature teratoma, more irregular calcification and solid components predominate.
Report Sentence
Coexistence of fat density and calcification within the retroperitoneal mass suggests teratoma component.
On T2-weighted MRI, the mass shows markedly heterogeneous signal. Cystic/necrotic areas show very high T2 signal, solid tumor tissue intermediate signal, and hemorrhage areas variable signal depending on stage. In teratoma components, fat shows high T2 signal and calcification very low signal. Seminomas show relatively more homogeneous intermediate-to-high T2 signal, while non-seminomatous tumors show marked heterogeneity. On DWI, solid components demonstrate diffusion restriction.
Report Sentence
On MRI, the retroperitoneal mass demonstrates markedly heterogeneous signal on T2-weighted sequences, containing solid, cystic, necrotic, and hemorrhagic components.
Solid tumor components demonstrate diffusion restriction on DWI — hyperintense at high b-values (b=800-1000) and hypointense on ADC map. Cystic/necrotic areas do not show diffusion restriction (T2 shine-through may occur but ADC shows high signal). Degree of diffusion restriction is proportional to cellularity: high-grade components (embryonal carcinoma, yolk sac) show more marked restriction than low-grade components (mature teratoma).
Report Sentence
Solid components of the retroperitoneal mass demonstrate diffusion restriction on DWI, consistent with high cellularity.
On US, a large, complex, heterogeneous mass in the retroperitoneal region is observed. Solid components show variable echogenicity, cystic areas may be anechoic or contain internal echogenicity (hemorrhage/debris). In teratoma components, echogenic calcification or bone structures may be seen with posterior acoustic shadowing. Fat-containing areas show echogenic appearance. US is critical for testicular evaluation — both testes should be examined to detect 'burned-out' testicular tumor or synchronous gonadal tumor.
Report Sentence
Large, complex, heterogeneous mass in the retroperitoneal region on US; both testes should be evaluated ultrasonographically.
Variable FDG uptake is observed on FDG PET-CT depending on subtype. Seminomas generally show intense FDG uptake (SUVmax >5). In non-seminomatous tumors, uptake is heterogeneous — embryonal carcinoma and yolk sac tumor show intense uptake, while mature teratoma shows minimal or no uptake. PET-CT is particularly valuable in post-treatment residual mass evaluation: residual FDG uptake in seminoma indicates viable tumor, while low/negative FDG in teratoma does not exclude residual disease.
Report Sentence
Intense FDG uptake in solid components of the retroperitoneal mass on PET-CT (SUVmax: ___); minimal or no uptake in teratoma components.
Criteria
Homogeneous solid mass in retroperitoneum, normal AFP, beta-hCG normal or mildly elevated, elevated LDH. Uniform seminoma cells on histology.
Distinct Features
Radiosensitive and chemosensitive, best prognosis. Relatively homogeneous enhancement on CT. Intense FDG uptake on PET. Cisplatin-based chemotherapy ± radiotherapy. 5-year survival >80%.
Criteria
Heterogeneous mass, markedly elevated AFP and/or beta-hCG. Embryonal carcinoma, yolk sac tumor, choriocarcinoma, or mixed components.
Distinct Features
More aggressive course, cisplatin-based chemotherapy + surgical resection (post-chemotherapy RPLND). Choriocarcinoma has high hemorrhage risk. 5-year survival 40-60%. Residual teratoma must be resected ('growing teratoma syndrome' risk).
Criteria
Well-defined predominantly cystic mass containing fat and calcification, normal tumor markers. Mature differentiated tissue components on histology.
Distinct Features
Benign behavior but surgical resection required (malignant transformation risk). Fat-calcification coexistence diagnostic on CT. Minimal FDG uptake on PET. Long-term follow-up needed (growing teratoma syndrome).
Distinguishing Feature
Retroperitoneal lymphoma typically encases great vessels, shows homogeneous low-intermediate density without fat/calcification. EGGCT displaces vessels, may contain fat and calcification, and tumor markers (AFP, beta-hCG) are elevated.
Distinguishing Feature
Retroperitoneal sarcomas typically occur at older age with normal tumor markers and different histological pattern. Liposarcoma may contain fat but calcification is rare. EGGCT is distinguished by young males and elevated AFP/beta-hCG.
Distinguishing Feature
Retroperitoneal paraganglioma shows hypervascular enhancement, may be functional (catecholamine elevation), and typically located along aortosympathetic chain. EGGCT shows heterogeneous enhancement, may contain fat/calcification, and has different tumor markers.
Distinguishing Feature
Wilms tumor starts as an intrarenal mass displacing renal parenchyma ('claw sign'); EGGCT is an extrarenal retroperitoneal mass displacing the kidney externally. Age group (Wilms <5 years, EGGCT 20-35 years) and tumor markers are also distinguishing.
Urgency
urgentManagement
medicalBiopsy
NeededFollow-up
specialist-referralTreatment of extragonadal germ cell tumor is determined by histological subtype and requires multidisciplinary approach. Bilateral testicular ultrasound should be performed in all patients ('burned-out' tumor investigation). Seminomas respond well to cisplatin-based chemotherapy (BEP regimen) ± radiotherapy. In non-seminomatous tumors, post-chemotherapy residual mass surgery (RPLND) is planned — residual teratoma must be resected. Tumor markers (AFP, beta-hCG, LDH) are critical for monitoring treatment response and recurrence. Tumors with choriocarcinoma component carry significant hemorrhage risk requiring urgent treatment initiation.
Extragonadal GCT is a rare but treatable tumor. Cure is possible with cisplatin-based chemotherapy + surgery. Gonadal primary must be excluded (US + exam). AFP and beta-hCG monitoring assesses treatment response. The possibility of burned-out gonadal GCT should be kept in mind.